JAN 05, 2021 2:21 PM PST

Integrator: A New Type of Transcriptional Control is Discovered

WRITTEN BY: Carmen Leitch

The study of the genome once seemed like a straightforward process: a specific short sequence of three nucleotide bases in DNA was a sign that indicated where a protein's sequence began. This three-base-pair sequence is known as a start site and is where an enzyme called RNA polymerase II starts to transcribe a DNA sequence into an RNA sequence. That RNA sequence is used to make the protein the gene encodes for.

Image credit: Pixabay

But scientists have learned over the years that it’s not quite that simple. There are start sites scattered all over the genome, and sometimes they have no relation to a protein. It seems that cells are relatively promiscuous in their use of RNA polymerase II, and lots of non-functional products end up getting generated by this system. That means that the cell has to have robust quality check mechanisms to prevent these by-products of transcription from accumulating in the cell or causing damage.

Researchers have now learned more about the role of a protein complex called integrator in this process. Reporting in Molecular Cell, the study authors showed that integrator, which was previously shown to act to end transcription for a small group of small nuclear RNAs, actually works to terminate transcription early for many (if not all, they suggest) RNA polymerase II initiation events. In the case of such early termination, a very short transcript is generated that can easily and quickly be disposed of by the cell.

Many protein-coding genes that produce long transcripts have features that are able to prevent early termination. So, integrator is able to reduce the production of aberrant or wasteful transcripts while thousands of start sites are still able to retain their place in the genome. This enables the cell to select for the best transcripts; a reservoir of transcribed sequences is generated, some of which can be turned into functional genes while others can be discarded.

In the case of snRNAs, integrator can terminate a transcript early, but the cell may retain the transcript to produce a functional RNA molecule.

When mutations occur that cause the inactivation of parts of the integrator complex, neurodevelopmental disease can occur. If portions of integrator are expressed at abnormally high levels, there is an increase in a process that is linked to tumor metastasis called epithelial to mesenchymal transition. Integrator’s activity, therefore, seems to be critical, and subject to careful control. 

This work may eventually open up our understanding of these neurodevelopmental disorders and may lead to new ways to treat them.

Sources: AAAS/Eurekalert! via Aarhus University, Molecular Cell

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
NOV 30, 2020
Genetics & Genomics
Green Genetic Technology Can Help Feed the World
NOV 30, 2020
Green Genetic Technology Can Help Feed the World
In the latter half of the last century, agriculture underwent a technological revolution that enabled farmers to create ...
DEC 04, 2020
Genetics & Genomics
An 'Off' Switch to Improve CRISPR Precision
DEC 04, 2020
An 'Off' Switch to Improve CRISPR Precision
The CRISPR-Cas9 gene-editing tool has tremendous potential to treat genetic diseases, but sometimes it makes unintended ...
DEC 06, 2020
Genetics & Genomics
New Epigenetic Signature Discovered in Zebrafish
DEC 06, 2020
New Epigenetic Signature Discovered in Zebrafish
Zebrafish are a great model organism for biomedical research. They generate large numbers of embryos that develop rapidl ...
DEC 17, 2020
Genetics & Genomics
Using Tomatoes to Produce a Parkinson's Drug
DEC 17, 2020
Using Tomatoes to Produce a Parkinson's Drug
More and more people are being diagnosed with Parkinson's disease as the world's population ages. Scientists have now en ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
Loading Comments...